Matthew C. Riddle
Oregon Health & Science University(US)Oregon Medical Research Center(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,890 cited
- → Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome(2015)2,293 cited
- → Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure(2020)1,767 cited
- → Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial(2018)1,728 cited
- → The Treat-to-Target Trial(2003)1,472 cited
- → Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea(2005)1,175 cited